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Abstract
Many neurotropic strains of Escherichia coli cause potentially lethal bacteraemia and meningitis in
newborn infants by virtue of their capacity to elaborate the protective polysialic acid (polySia) K1
capsule. Recombinant capsule depolymerase, endosialidase E (endoE), selectively removes
polySia from the bacterial surface; when administered intraperitoneally to infected neonatal rats,
the enzyme interrupts the transit of E. coli K1 from gut to brain via the blood circulation and
prevents death from systemic infection. We now show that experimental E. coli K1 infection is
accompanied by extensive modulation of host gene expression in the liver, spleen and brain tissues
of neonatal rats. Bacterial invasion of the brain resulted in a threefold or greater upregulation of
approximately 400 genes, a large number of which were associated with the induction of
inflammation and the immune and stress responses: these included genes encoding C–X–C and C–
C chemokines, lipocalins, cytokines, apolipoproteins and enzymes involved in the synthesis of
low-molecular-mass inflammatory mediators. Administration of a single dose of endoE, 24 h after
initiation of systemic infection, markedly reduced, but did not completely abrogate, these changes
in gene expression, suggesting that attenuation of E. coli K1 virulence by removal of the polySia
capsule may minimize the attendant inflammatory processes that contribute to poor outcome in
these severe systemic infections.
INTRODUCTION
A wide range of encapsulated and capsule-free bacteria are able to gain entry to, and
establish infection in, the blood compartment (Reacher et al., 2000) but, in the absence of
trauma or other forms of tissue injury, relatively few are able to invade the central nervous
system (CNS) from the systemic circulation. Those that do invariably elaborate a
polysaccharide capsule that provides protection from both humoral and cellular host
defences (Tunkel & Scheld, 1993; Davidsen et al., 2007). In neonatal bacterial meningitis
(NBM), a leading cause worldwide of mortality and morbidity in newborn infants (Harvey
et al., 1999), up to 80 % of cases in industrialized countries are caused by just two
© 2010 SGM
Correspondence: Peter W. Taylor, peter.taylor@pharmacy.ac.uk.
Microarray data accession number: ArrayExpress E-MEXP-2406.
Five supplementary tables are available with the online version of this paper, listing primer pairs for amplification of genes examined
using qRT-PCR for validation of microarray results, genes in neonatal rat liver and spleen altered in response to infection with E. coli
K1, and genes upregulated more than threefold in neonatal rat liver and spleen following administration of endoE.
Europe PMC Funders Group
Author Manuscript
Microbiology. Author manuscript; available in PMC 2011 July 01.
Published in final edited form as:
Microbiology. 2010 July ; 156(Pt 7): 2205–2215. doi:10.1099/mic.0.036145-0.
 Europe PM
C Funders A
uthor M
anuscripts
 Europe PM
C Funders A
uthor M
anuscripts
encapsulated species: group B streptococci and Escherichia coli (Bonacorsi & Bingen, 2005;
May et al., 2005). Of the neuroinvasive E. coli isolates, 80–85 % express the K1 capsule
(Robbins et al., 1974), a homopolymer of α-2,8-linked polysialic acid (polySia) that mimics
the molecular structure of the polySia modulator of neuronal plasticity in mammalian hosts
(Rutishauser, 2008). In experimental E. coli K1 infection, the capacity to invade the CNS is
critically dependent on polySia expression (Kim et al., 1992) and the capsule contributes
significantly to the overall virulence of K1 strains (Bortolussi et al., 1978).
The continuing rise in the incidence of infections due to multi-drug-resistant bacteria has
stimulated interest in the development of new antibacterial therapeutic paradigms based on
the modulation of virulence: disarming pathogens by reducing the expression of virulence
determinants essential for bacterial colonization, dissemination and survival within the host
should enable immune defences to overwhelm the attenuated invader (Cegelski et al., 2008;
Taylor et al., 2009). Studies from the pre-antibiotic era demonstrated that compromising the
expression at the bacterial surface of the protective capsule facilitates rapid and effective
resolution of potentially lethal bacterial infections (Avery & Dubos, 1931; Goodner et al.,
1932; Francis et al., 1934). In similar fashion, we investigated the effect of enzyme-
mediated selective removal of polySia on the course of infection in a model, adapted from
Glode et al. (1977), that replicates many of the key features of the infection in the human
neonate (Mushtaq et al., 2004, 2005).
Two-day-old rats were fed E. coli K1 and the bacteria efficiently colonized the
gastrointestinal (GI) tract within 24 h (Mushtaq et al., 2004). The bacteria then gained entry
to the blood compartment, where they expressed the non-O-acetylated form of polySia
(Zelmer et al., 2008); they subsequently accessed the CNS, probably through the blood–
cerebrospinal fluid (CSF) barrier at the choroid plexus, a well-established portal for bacterial
invasion of brain tissue (Nau & Brück, 2002). E. coli K1 could be localized in the meninges
of rat pups using immunohistological techniques but, whilst the LPS O18 antigen at the
bacterial surface could be readily visualized within brain sections at the neuronal cell–
meningeal interface, no evidence was found for expression of O-acetylated or non-O-
acetylated polySia in this protected niche (Zelmer et al., 2008). Intraperitoneal (i.p.)
administration of a polySia-specific capsule depolymerase (Tomlinson & Taylor, 1985;
Leggate et al., 2002) during the early phases of the infection prevented bacteraemia
(Mushtaq et al., 2004, 2005), meningeal invasion (Zelmer et al., 2008) and death (Mushtaq
et al., 2004) from E. coli K1 infection, although colonization of, and persistence within, the
GI tract was not interrupted (Mushtaq et al., 2004). These studies, along with recent
investigations of anti-anthrax therapies (Scorpio et al., 2007, 2008), demonstrate the
therapeutic efficacy of the ‘capsule-stripping’ approach.
In the K1 model, as in the natural infection in humans, the bacterial inoculum is acquired
orally, susceptibility to infection is strongly age-dependent, bacterial invasion of the blood
compartment is preceded by GI tract colonization, pathogenesis is dependent on expression
of polySia at the bacterial surface and infection of the brain is limited to sites within the
meninges, a distribution compatible with CNS entry via the choroid plexus and CSF (Tunkel
& Scheld, 1993; Davidsen et al., 2007). NBM is usually accompanied by extensive
inflammation of the CNS and it is these local reactions, rather than the pathogen itself, that
are largely responsible for the tissue damage associated with meningitis; indeed, progressive
damage to the brain may accumulate after the site of infection has been rendered free of
invading bacteria by chemotherapy (Täuber & Moser, 1999). Local induction of
proinflamma-tory cytokines such as TNF-α, IL-1 and IL-6, a feature of bacterial meningitis,
can be replicated by injection of LPS in models of the disease (Ramilo et al., 1990; Täuber
& Moser, 1999), and release of endotoxin following antibiotic therapy in infants with E. coli
meningitis exacerbates the severity of the infection and increases mortality (Mustafa et al.,
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1989). Failure of E. coli K1 to express polySia in the meninges will expose LPS as the
outermost layer of the bacterial cell, resulting in a high probability of local cytokine and
chemokine induction. The current study was designed to examine the degree of induction of
a local transcriptional response to meningeal invasion by E. coli K1 and to determine the
capacity of the polySia-specific capsule depolymerase endosialidase E (endoE) to prevent
local inflammatory and tissue damage responses to the bacterial insult. The data indicate that
interruption of the course of infection reduces, but does not completely abrogate, the local
tissue response to bacterial invasion.
METHODS
Bacteria and capsule depolymerase
E. coli O18 : K1 strain A192PP was derived from E. coli A192, an isolate from a patient
with septicaemia (Achtman et al., 1983), by serial passage through neonatal rat pups as
described previously (Mushtaq et al., 2004; Zelmer et al., 2008); the passaged strain was
significantly more virulent in the rat pup model of infection than E. coli A192 (Mushtaq et
al., 2005). His6-tagged endoE was produced in E. coli BL21(DE3) and purified by Ni-
affinity chromatography as described previously (Mushtaq et al., 2004). Recovered protein
was pure as judged by SDS-PAGE, with no proteins detectable other than the 76 kDa
recombinant endoE fusion product. Kinetic properties and stability of the recombinant
enzyme are reported elsewhere (Leggate et al., 2002; Mushtaq et al., 2004). For i.p.
administration, 20 μg doses of recombinant endoE for individual rat pups were formulated
in 100 μl PBS.
Infection of neonatal rats and processing of tissues
Wistar rat litters (9–14 individuals), obtained from Harlan UK or bred in-house, were
retained in a single cage with their natural mothers after birth. To establish infection by GI
tract colonization, all members of a litter were fed 20 μl of mid-exponential-phase Mueller–
Hinton (MH) broth culture of E. coli A192PP (2–6×106 c.f.u. at 37 °C) from an Eppendorf
micropipette (Mushtaq et al., 2004). Intestinal colonization was assessed at 24 h intervals by
MacConkey agar culture of perianal swabs; the presence of K1 in individually plated
colonies was determined using phage K1E (Gross et al., 1977) as described previously
(Mushtaq et al., 2004). Bacteraemia was detected by culture of blood samples taken from
superficial veins in the footpad on MacConkey agar; K1 expression of individually plated
colonies was detected with phage K1E. Animals were killed by decapitation and further
blood samples taken at this stage for c.f.u. enumeration. Post-mortem, the brain, liver and
spleen were excised aseptically, and each organ was cut into two pieces along the
longitudinal axis of symmetry. One portion was transferred to 1 ml cold PBS and gently
washed to remove blood; the washing process was repeated twice. The sample was then
homogenized in 1 ml PBS using an Ultra-Turrax T8 homogenizer (IKA Werke).
Homogenized aliquots were serially diluted and plated for bacterial enumeration; a selection
of colonies was examined for K1 expression using phage K1E. The other portion was
immediately placed in the RNA and tissue fixative RNAlater (Ambion) and maintained
overnight at 4 °C; the tissue was then removed from the solution and stored at −70 °C prior
to further processing. Control animals were fed 20 μl sterile MH broth and their organs and
blood were processed in the same way as for K1-infected animals.
Serum cytokine assays
Serum was obtained from blood removed after cull of P4 rat pups and levels of IL-1β, IL-6,
TNF-α and IL-10 were determined by ELISA assay, using appropriate antigen-affinity-
purified anti-rat antibody pairs and detection reagents and rat recombinant cytokines as
standards (capture antibodies: rabbit anti-rat in all cases; detection antibodies: biotinylated
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rabbit anti-rat IL-1β, IL-10 and TNF-α, biotinylated goat anti-rat IL-6; Peprotech). All
assays were performed at least three times and were highly reproducible.
Affymetrix GeneChip analysis
RNA was extracted from individual organs (liver, brain and spleen) using the Qiagen
RNeasy Animal Tissue Midi kit. RNA integrity and concentration were determined with a
Bioanalyser 2100 (Agilent) and a NanoDrop 1000 (Thermo Scientific). Labelled cDNA was
hybridized to Affymetrix GeneChip Rat Genome 230 2.0 arrays (Affymetrix). The arrays
comprised over 31 000 probe sets representing variants from more than 28 000 rat genes;
there are 11 probe sets represented for each coding sequence (http://www.affymetrix.com).
GeneChip expression analysis was performed using a sample extracted from uninfected rat
pups of similar age to the reference control. Labelled cDNA synthesis, fragmentation,
hybridization, washing and scanning of rat genome arrays were performed according to the
Affymetrix GeneChip Expression Analysis Technical Manual (702232; Rev. 2).
Hybridizations were incubated for 16 h at 45 °C. GeneChips were scanned using an
Affymetrix Gene Array Scanner 3000. Hybridization data were analysed on GeneChip
Operating Software (GCOS v1.4). DAT, CEL and CHP files were removed using the Data
Transfer Tool (v1.1.1); CEL files were imported into the third-party data analysis software
GeneSpring v7.3 (Agilent). GC-RMA normalization was performed on all data generated
using a chip from a comparable uninfected rat pup as reference.
Quantitative RT-PCR (qRT-PCR)
RNA was extracted from brain, liver and spleen using the RNeasy Animal Tissue Midikit
protocol (Qiagen) to ensure no DNA contamination. qRT-PCR was carried out using the
Brilliant II SYBR Green QRT-PCR 1-Step kit (Stratagene). Briefly, 25 ng DNA-free RNA
was used as template for each qRT-PCR in conjunction with gene-specific primer pairs
(synthesized by Eurofins MWG Operon) designed using Clone Manager (Sci-Ed Software)
for genes of interest to yield amplicons of 100–150 bp. The conditions for the qRT-PCR
were: one cycle each of 50 °C for 30 s and 95 °C for 10 min, followed by 55 cycles of 95 °C
for 30 s, 60 °C for 30 s, and 72 °C for 30 s. Each reaction plate was duplicated and included
‘no template’, ‘no reverse transcriptase’, and ‘melting-curve analysis’ controls. All reactions
were duplicated on each plate and performed using an Mx3000P instrument (Stratagene).
The comparative threshold method was used to determine relative quantification of mRNA
abundance and changes in mRNA expression level were calculated after normalization to
the internal control gene, actB. The nucleotide sequences of the primers used in this study
are presented in Supplementary Table S1, available with the online version of this paper.
RESULTS
Effect of single doses of endoE on progression of neonatal systemic infection
Feeding E. coli A192PP to 2-day-old (P2) rat pups led to GI tract colonization within 24 h
(Fig. 1a). Bacterial translocation to the blood compartment began at P3–P4. By P7, the
overwhelming majority of pups (90–100 %) yielded blood cultures that were positive for E.
coli K1 and all bacteraemic animals had died by P9 (Fig. 1b). A requirement for polySia
capsule expression during the early stages of infection was demonstrated by i.p.
administration of endoE at P3; a single dose of the recombinant enzyme prevented death in
95–100 % of pups (Fig. 1b) and the animals remained healthy in spite of the fact that many
displayed a transient bacteraemia (Fig. 1a). Bacterial blood counts were far higher and
persisted for a longer period of time in untreated animals compared with those infected pups
dosed with endoE (data not shown). EndoE had no effect on GI colonization by E. coli K1
(Fig. 1a).
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Changes in organ gene expression following E. coli K1 infection
Pups were fed E. coli A192PP at P2; all litter members were infected in identical fashion
and at the same time. Infected animals were culled at P4 and brain, liver and spleen removed
for determination of bacterial burden and for RNA extraction. The rationale for choice of
tissues was based on prior observations (Zelmer et al., 2008): in our infection model, E. coli
K1 traffics to the brain via the CSF and invades the meninges; bacteria associate with liver
and spleen during the infection process and as major organs of the mononuclear phagocyte
system they are likely to be involved in the removal of bacteria from the systemic
circulation.
To evaluate the effect of severe systemic infection with E. coli K1 on organ gene expression
and to ensure that RNA samples were obtained from the three different organs of animals at
similar stages of the infectious process, three pups with blood counts in excess of 1×106
c.f.u. ml−1 were selected for further investigation (Table 1). As anticipated (Zelmer et al.,
2008), the bacterial burden in the brain, liver and spleen of these pups was substantial; for
example, in two animals (41.7 and 41.8), counts from the brain tissue exceeded 109 and in
the third pup (43.7) the burden was below 106. To gauge the extent to which brain
involvement was accompanied by evidence of sepsis, blood levels of the pro-inflammatory
cytokines IL-1β, IL-6 and TNF-α and the anti-inflammatory cytokine IL-10 were measured.
Levels of IL-1β, IL-6, IL-10 and TNF-α were below the detection limit (0.06 ng ml−1) in
sham-treated control animals but high levels of the three pro-inflammatory cytokines and
anti-inflammatory IL-10 were detected in serum from infected pups 41.7 (IL-1β, 3.8 ng
ml−1; IL-6, 2.1 ng ml−1; IL10, 0.4 ng ml−1; TNF-α, 15.0 ng ml−1) and 41.8 (IL-1β, 2.3 ng
ml−1; IL-6, 4.1 ng ml−1; IL10 0.8 ng ml−1; TNF-α: 15.8 ng ml−1). Insufficient serum was
obtained from pup 43.7 to permit evaluation of systemic cytokine levels.
RNA extracted from brain, liver or spleen of the three severely infected animals was
combined in equimolar amounts to create organ-specific pools and labelled cDNA samples
derived from these pools were hybridized and compared with hybridized pooled sham-
control labelled cDNA obtained from the corresponding organs of three uninfected pups. A
strict threefold cut-off was applied in order to assess the more definitively differentially
regulated genes once GeneChip Robust Multiarray Averaging (GCRMA) normalization had
been performed. This is a greater stringency than used in some similar studies (Boyce et al.,
2002; Woodall et al., 2005) and was applied to ensure that differentially expressed data were
selected on the basis of biological relevance. Fully annotated microarray data from these
experiments have been deposited in ArrayExpress (accession no. E-MEXP-2406): the gene
expression from pooled brain tissue showed that 416 genes were upregulated threefold or
more and 77 were downregulated at least threefold. The corresponding figures for pooled
liver were 570 and 735, and for spleen 893 and 114 respectively. Modulated genes were
spread across a wide range of functional categories but it was evident that a higher
proportion of upregulated genes from brain tissue of infected rats were associated with
inflammatory, immune and stress-induced phenomena, compared with the liver and spleen
responses. In contrast to the liver response, modulation of gene expression in the brain was
characterized by marked upregulation and modest downregulation (Table 2).
With both pooled liver and spleen arrays, upregulated infection-induced genes belonged to a
wide range of functional categories, with genes involved in growth, differentiation,
development, inflammation, the immune and stress responses, cell metabolism,
transcriptional regulation and transport strongly represented (Table 2). Examples of genes
that were strongly modulated are detailed in Supplementary Table S2 (liver) and
Supplementary Table S3 (spleen). In liver, levels of gene expression of both C–X–C and C–
C chemokines were markedly increased during infection, and genes involved in lipid
metabolism, cholesterol and steroid biosynthesis and the innate immune response were also
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prominently upregulated (Table 2, Supplementary Table S2). Evidence for a major
reprogramming of liver metabolism in response to systemic E. coli K1 infection was further
supported by extensive downregulation of genes in most functional categories. As a major
lymphoid organ involved in blood filtration, the spleen responded to large numbers of K1
bacteria with a significant degree of gene upregulation. Very large increases in expression of
genes encoding proteins involved in angiogenesis and tissue remodelling, such as
fibrinogen, were evident (Supplementary Table S3), as were genes encoding proteins
associated with the innate immune response. As with liver, spleen levels of C–X–C and C–C
chemokines were increased (19.7-fold to 382.2-fold). Large increases in genes involved in
splenic synthesis of complement components C9 (180.6-fold), factor I (54.4-fold), C3 (49.3-
fold), factor H (39.5-fold) and C4-binding protein β (29.1-fold) contributed to a vigorous
innate response, and a number of genes encoding apolipoproteins were also upregulated:
apoA-V (66.4-fold), apoA-I (35.7-fold), apoH (35.4-fold), apoCI (20.0-fold), apoCIII (15.6-
fold) and apoE (12.4-fold). Downregulation of genes in spleen samples was relatively
modest (Table 2).
A high proportion of upregulated genes in pooled brain tissue from infected P4 pups was
indicative of a vigorous local inflammatory response (Table 2). Some genes showed
extremely large increases in the level of transcription following systemic infection and these
were, in the main, associated with inflammatory and immune processes. Table 3 shows
those genes that were upregulated to the greatest extent. Transcription of genes encoding C–
X–C chemokine ligands 1, 2, 10 and 11 increased at least 200-fold, and cxcl9 and cxcl16
were overexpressed fourfold and fivefold respectively. Genes encoding C–C chemokine
ligands 20 (751-fold), 2 (633-fold), and 5 (15-fold) were also highly upregulated, as were
genes encoding complement components C3, C2, C1r, C1s and properdin. The full
ArrayExpress gene lists indicated that a number of genes associated with protein
ubiquitylation (Bhoj & Chen, 2009) were significantly upregulated. No clear pattern
emerged from analysis of the relatively small number of genes that were downregulated
after infection (Table 2).
Effect of endoE administration on organ gene expression
Intraperitoneal administration of a single 20 μg dose of endoE at P3, 24 h after the seeding
of the K1 infection resulted in large reductions in bacterial organ counts at P4, in some cases
completely eradicating the infection. Three P4 pups showing evidence of residual bacteria in
blood, liver, spleen or brain following endoE administration (Table 1) were selected for
investigation of organ gene expression. No detectable levels of cytokines IL-1β, IL-6, IL-10
and TNF-α, determined by ELISA, were found at P4 in infected pups treated with endoE.
Gene expression analysis showed that endoE treatment prevented infection-induced
upregulation of the majority of genes in pooled liver samples: a total of only 32 genes, 19 of
which possessed known functions, were overexpressed threefold or more. These included
genes encoding pancreatitis-associated protein (pap; 28-fold) and orosomucoid 1 (7.2-fold),
both characteristic of an acute-phase response, tryptophan hydroxylase (Tph; 84.2-fold),
involved in serotonin synthesis, and lipocalin 2 (6.2-fold). The majority (19 of 32) were
overexpressed less than fourfold. Similarly, only 18 splenic genes were upregulated in
pooled endoE-treated samples: tph (13.6-fold) and pap (4.5-fold) were again evident.
However, 735 genes from liver samples and genes from 1834 splenic samples, representing
all categories listed in Table 2, were down-regulated in P3-treated P4 pups compared with
uninfected sham controls, the large majority between three- and fivefold.
Although we were unable to obtain sufficient material to examine transcription in liver and
spleen samples from individual animals, it was possible to obtain microarray data from brain
tissue harvested from the three individual animals detailed in Table 1. There was some
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variation between brain samples with respect to the numbers of genes up and downregulated
threefold or more in individual rat pups within infected and infected treated groups (Fig. 2,
Table 4). It is evident from the linear scatter plots shown in Fig. 2 that gene expression
profiles of infected pups receiving an i.p. dose of endoE were significantly different from
those of infected but untreated animals seeded with lethal numbers of E. coli K1. However,
in infected, untreated P4 pups, genes that were over-expressed to the greatest extent were
those found to dominate the pooled gene lists (Table 3 and ArrayExpress lists). Brain tissue
from pup 43.7 showed upregulation of fewer genes than either pups 41.7 or 41.8, and down-
regulation of a greater number than in these animals. Very few genes differentially regulated
in brain samples were found to be even modestly (usually less than fivefold change)
overexpressed in endoE-treated animals, in comparison with uninfected controls, and no
obvious pattern was evident, although the gene encoding Map1b (microtubule-associated
protein 1b) was upregulated in tissues from endoE-treated pups 45.2 and 45.4.
Downregulated genes in both infected and treated animals belonged to a broad range of
functional groups.
It was clearly important to determine if administration of endoE to healthy animals
significantly affected gene expression. Therefore, 20 μg endoE was administered i.p. to
three uninfected P3 pups, and the liver, spleen and brain were removed post mortem 24 h
later. Tissues were processed as described above and gene expression profiles determined
using pooled RNA from liver and spleen samples and RNA from brain tissue of individual
pups. That endoE distributed to the systemic circulation from the peritoneal cavity was
indicated by a threefold or greater upregulation of 21 genes in the liver and 36 genes in the
spleen (see Supplementary Tables S4 and S5, respectively); a high proportion of the genes
overexpressed in the spleen encoded protein-degrading enzymes (Supplementary Table S5).
None of the genes in either liver or spleen were found to be upregulated in the
corresponding tissues from infected (at P2), endoE-treated (at P3) pups when examined at
P4 (ArrayExpress files). There was no upregulation of genes in brain samples from any of
the three pups.
To confirm the validity of the microarray data, 11 genes (Table 5, Supplementary Table S1)
were selected for qRT-PCR analysis; genes with varying degrees of modulation of
expression were examined. Pearson correlation coefficient demonstrated a significant
correlation (P=<0.0001) and an R2 value of 0.9340, equivalent to a 93.40 % correlation,
between the two methods of assessment of gene expression.
DISCUSSION
In human NBM, the release of bacterial wall components within the CNS stimulates a
complex host response involving humoral and cellular immune mediators, reactive oxygen
intermediates, matrix metallopeptidases, and other host-derived factors, leading eventually
to functional and structural brain damage (Leib & Täuber, 1999; Yadav et al., 2009).
Cerebral white matter injury in neonates following E. coli K1 meningitis is particularly
severe (Shah et al., 2005) and is strongly influenced by poorly defined host genetic factors
(Lyons et al., 2009). Local inflammation results initially from binding of LPS and other
bacterial products to CD14 molecules on monocytes and macrophages, leading to synthesis
of a large number of cytokines and chemokines that drive an innate response that often fails
to control or eliminate the pathogen (Täuber & Moser, 1999). The proinflammatory
cytokines IL-1β, IL-6 and TNF-α are present in CSF during meningitis and are produced
locally (Møller et al., 1991; Täuber & Moser, 1999); the concentrations of these effectors in
serum are usually only elevated in meningitis when patients display signs of accompanying
sepsis (Täuber & Moser, 1999). In addition, C–X–C and C–C chemokines often feature
prominently in the CSF of bacterial meningitis patients (Inaba et al., 1997; Spanaus et al.,
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1997), as do the anti-inflammatory cytokines IL-10 and TGF-β, indicating the complexity of
the host response to meningitis pathogens.
It is clear from the present study that the E. coli K1 neonatal rat model that we employ
replicates in broad terms the local tissue inflammatory response associated with bacterial
meningitis in humans (Täuber & Moser, 1999; Polin & Harris, 2001), at least in animals
with a very high blood and brain bioburden. In our model, all members of a litter are
infected concomitantly but the time of initiation and the extent of bacteraemia and tissue
involvement vary over the course of 2–5 days post-infection (Mushtaq et al., 2004) and for
this reason we selected for study those animals showing extensive bacteraemia at P4, rather
than pooled tissues from all animals in an infected litter. It is highly likely that the selected
animals were close to death and are examples of overwhelming infection that may not be
typical of many examples of the human disease, but they provide an opportunity to
determine the potential degree of host gene modulation during overt, late-stage infection.
The profound changes in gene expression in the liver and spleen, featuring a wide range of
host functions, are likely to represent an attempt to enrich the supply of immune mediators,
such as various complement components and cell adhesion molecules, to defend the organ
against stress-induced damage and to clear the invading bacteria. We provide strong
evidence that these organs also mount a local inflammatory response.
A different pattern of infection-induced gene expression was detected in the brain, which is
the primary target organ for E. coli K1 in neonatal infection (Polin & Harris, 2001), as
evidenced by the particularly large number (400–500) of genes differentially regulated, most
of which were upregulated. The rodent brain is very active with respect to gene
transcription, with about 80 % of all genes concomitantly expressed in highly localized
fashion (Lein et al., 2007), and this infection-induced upregulation was therefore super-
imposed on an already highly active organ. Around 36 % of upregulated genes that could be
assigned to functional categories were associated with inflammatory, immune and stress
responses and a high degree of modulation of those cytokines and chemokines indicative of
local tissue responses in the human neonate (Täuber & Moser, 1999) was evident; also
prominent were genes encoding proteins involved in serotonin and prostaglandin synthesis,
lipid transport and catabolism, complement activation, tissue remodelling and lipocalin
synthesis (Table 3); the latter family of proteins are associated with regulation of the
inflammatory response to LPS-mediated endotoxaemia (Sunil et al., 2007). In two of the
three infected pups, we found evidence of systemic levels of key cytokines, suggesting a
threshold level of sepsis related to the bacterial burden in the blood circulation. Fewer genes
were over-expressed in brain tissue from pup 43.7 (Table 4), which carried a lower
bioburden than either pup 41.7 or pup 41.8, but the ArrayExpress data files clearly show that
the prominent, highly upregulated genes (some of which are shown in Table 3) feature
prominently in microarray data from all three pups. In the light of these responses we are
planning further, more extensive studies of the transcriptional response in animals with less
severe infection. We have previously shown that, following penetration of the meninges by
E. coli K1 strain A192PP, the polySia capsule does not appear to be expressed at the
bacterial surface (Zelmer et al., 2008). It is likely that unmasking of the LPS-containing
outer membrane exacerbates the local inflammatory response and we intend to determine if
sites of synthesis of immune mediators coincide with bacterial foci of meningeal infection.
Conventional antibiotic chemotherapy in neonatal meningitis generally involves
combinations of broad-spectrum antibiotics, usually including an aminoglycoside and a
third-generation cephalosporin, administered for 2 or 3 weeks (Polin & Harris, 2001;
Fernando et al., 2008). Such regimens are likely to engender the release of cell wall
components, in particular LPS, which will continue to drive local inflammation despite the
high likelihood that use of these antibiotics will eradicate the infectious agent; residual
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bacterial components almost certainly contribute to ongoing damage to the CNS in the
absence of the pathogen in these infections (Täuber & Moser, 1999). One potential benefit
of the ‘capsule-stripping’ approach is that enzyme-mediated attenuation is likely to prepare
the K1 bacteria for uptake and disposal by phagocytic cells of the immune system (Mushtaq
et al., 2005) by processes that do not involve bacterial lysis and subsequent release of
proinflammatory mediators. The current study provides some evidence in favour of this
scenario, as dosing with endoE abrogates to a very large degree the overexpression of host
genes in the brain (Fig. 2), although it is highly probable that polySia is removed from the E.
coli surface during the blood phase of infection and relatively few bacteria transit to the
CNS in comparison to the situation in infected but untreated pups. Virtually all endoE-
treated animals remained healthy, displaying no symptoms of infection, even though low
numbers of bacteria could be cultured from the major organs. There was clear evidence
(Table 4), in spite of a successful therapeutic outcome following endoE administration, of
some reprogramming of gene transcription in the brain, but this did not appear to involve
significant upregulation of the local immune response. Interestingly, although administration
of endoE to healthy P3 pups did not result in any upregulation of gene expression in the
brain, a small number of genes were overexpressed in liver and spleen, suggesting that the
enzyme gained access to the blood compartment in these uninfected animals and was then
removed from the circulation by the major organs of the monocyte phagocytic system, as
evidenced by increased rates of transcription of protein-degrading enzymes, particularly in
the spleen. The liver and spleen genes upregulated by endoE did not appear to be modulated
in infected pups treated with endoE. ‘Capsule-stripping’ remains, therefore, a therapeutic
approach with the potential to prevent the induction of processes that contribute to the
significant mortality and morbidity associated with this severe systemic infection (Galiza &
Heath, 2009).
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Fig. 1.
Outcome of feeding E. coli K1 strain A192PP to 2-day-old (P2) rats. Animals were left
untreated or 20 μg endoE was administered at P3; n=20 in each group. (a) Colonization and
bacteraemia were determined daily over P3–P9, although E. coli expressing K1 were
detected in perianal swabs from almost all animals at P3. For purposes of statistical analysis
using the GraphPad Prism logrank test, pups were scored as bacteraemic if one or more
daily blood samples yielded K1-positive colonies, even if no bacteraemia was detected at
later time points. The difference regarding bacteraemia between the treated and control
group was highly significant (P=0.0001), whilst colonization was not significantly different
between the two groups (ns; P=0.4309). ■–■, Colonization control; ■- -■, colonization
treated; ●–●, bactaeremia control; ●--●, bacteraemia treated. (b) Deaths were recorded
over the period represented by P3–P9. Survival curves of treated and control animals are
significantly different (P<0.0001). ■–■, Survival control; ●- -●, survival treated.
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Fig. 2.
Modulation of gene transcription in the brain of individual rat pups 48 h after infection with
E. coli A192PP (a–c) and following i.p. administration of endoE to infected animals (d–f).
Rats were fed bacteria at P2 and culled at P4; endoE (20 μg) was dosed at P3. These linear
scatter plots compare expression of individual genes from infected or infected/treated
animals (y-axis) with uninfected P4 pups fed sterile MH broth at P2 (x-axis). Parallel lines
indicate twofold increase (green points) or decrease (blue points) of gene transcription. Data
were collated within GeneSpring v7.3, and genes up and downregulated threefold were
evaluated by Student's t-test (P<0.05). (a) Pup 41.7; (b) pup 41.8; (c) pup 43.7; (d) pup 45.1;
(e) pup 45.2; (f) pup 45.4.
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Table 1
Viable bacteria in blood and organs from E. coli A192PP-infected neonatal rat pups
Pups were fed 20 μl of E. coli A192PP culture 2 days after birth (P2), and blood and organs were harvested 48
h later (P4). For endoE treatment, the enzyme was administered i.p. to A192PP-fed pups at P3, and blood and
organs were harvested at P4.
Pup Intervention Brain* Liver* Spleen* Blood†
41.7None 24.45×108 12.20×106 31.75×104 >1×106
41.8None 12.28×108 31.05×107 25.07×106 >1×106
43.7None 57.5×104 17.60×106 16.28×106 >1×106
45.120 μg endoE 36 104 44 40
45.220 μg endoE 8 556 68 880
45.420 μg endoE 0 4 0 0
*
Total c.f.u. per organ.
†C.f.u. per ml blood.
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Table 3
Highly upregulated genes in neonatal rat brain following infection with E. coli K1
The 37 most highly upregulated genes of known function in pooled brain tissue from three infected pups are
listed.
Gene Gene name Function Fold change
Cxcl1 C–X–C chemokine ligand 1 Inflammatory response; chemotaxis 2229
Cxcl2 C–X–C chemokine ligand 2 Inflammatory response; chemotaxis 1668
Tph Tryptophan hydroxylase Serotonin biosynthesis 1419
Csf3 Colony stimulating factor 3 Immune response 767.8
Ccl20 C–C chemokine ligand 20 Inflammatory response; chemotaxis 751.5
Cxcl11 C–X–C chemokine ligand 11 Immune response 664.8
Ccl2 C–C chemokine ligand 2 Inflammatory response; chemotaxis 633.0
Il1b Interleukin 1β Inflammatory response 379.8
Il6 Interleukin 6 Acute phase/immune response 339.8
Mmp13 Matrix metallopeptidase 13 Proteolysis; collagen metabolism 302.2
Lcn2 Lipocalin 2 Transport/apoptosis 288.2
Cxcl10 C–X–C chemokine ligand 10 Inflammatory response; chemotaxis 286.7
Ptges Prostaglandin E synthase Prostaglandin synthesis; humoral response 182.1
Il1a Interleukin 1α Inflammatory response 181.0
Mmp9 Matrix metallopeptidase 9 Proteolysis; collagen metabolism 116.0
Plek Pleckstrin intracellular signalling cascade 99.4
Nos2 Nitric oxide synthase 2 NO synthesis; defence response to bacteria 85.9
Pglyrp1 Peptidoglycan recognition protein 1 Immune/defence response to bacteria 69.1
C3 Complement C3 Immune response: complement activation 68.7
Ptges Prostaglandin E synthase Prostaglandin synthesis; humoral response 62.1
Plscr1 Phospholipid scramblase 1 Immune response; phospholipid transport 62.0
Cebpd CCAAT/enhancer binding protein δ DNA-binding regulator of transcription 61.0
Sele Selectin (endothelial) Inflammatory/defence response 58.6
Serpine 1 Serine/cysteine proteinase
inhibitor
Blood coagulation; regulation angiogenesis 57.7
S100a8 Calgranulin A Acute inflammatory response; Ca2+ binder 57.3
Cd14 CD14 antigen Inflammatory/immune response 56.5
Pla2g2a Phospholipase A2, group IIA Lipid catabolism (platelets, synovial fluid) 54.7
Ptgs2 Prostaglandin-endoperoxide
synthase 2
Prostaglandin synthesis 53.6
Serpinb2 Serine/cysteine proteinase
inhibitor
Wound healing 53.6
Ccl4 Small inducible cytokine A4 Inflammatory response; chemotaxis 53.0
Il1rn Interleukin receptor antagonist Lipid metabolism; immune response 50.2
Bf B-factor, properdin Complement activation, alternative pathway 48.4
Plaur Plasminogen activator, urokinase receptor Blood coagulation; signal transduction 42.8
Cp Ceruloplasmin Copper/iron ion homeostasis 40.6
Icam1 Intercellular adhesion molecule 1 Cell–cell adhesion; immune cell migration 37.2
Timp1 Inhibitor of metalloproteinase 1 C21-steroid hormone biosynthesis 36.1
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Gene Gene name Function Fold change
Selp Selectin (platelet) Inflammatory response; cell adhesion 34.1
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Table 4
Up- and downregulated genes in brain tissue from individual rat pups infected with E. coli K1
Pup Intervention Up* Down*
41.7 None 403 77
41.8 None 299 60
43.7 None 157 560
45.1 20 μg endoE 11 159
45.2 20 μg endoE 7 92
45.4 20 μg endoE 6 94
*Number of genes modulated threefold or more at P4, compared with pooled brain tissue from sham-treated control P4 pups.
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Table 5
Comparison of fold-change in gene expression, as determined by microarray and qRT-PCR, in 11 genes
upregulated in neonatal rats infected with E. coli A192PP; qRT-PCR was performed using Brilliant II SYBR
Green chemistry and produced a significant correlation (P=<0.0001, R2=0.9340) with microarray results as
determined by Pearson correlation coefficient analysis
Gene symbol Fold-change
Microarray qRT-PCR
Ffg 706.4 625.92
Spin2c 625.6 683.25
A2m 582.9 434.95
Ccl2 111.9 149.92
Lcn2 85.21 215.92
Pglyrp1 30.48 89.24
Cp 27.95 4.02
Ptgs2 23.97 5.69
Icam1 20.01 15.27
RGD:621261 16.62 21.97
Cebpd 15.07 47.93
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